Related Experiment Videos
Silent myocardial ischemia after acute myocardial infarction
E E Van der Wall1, V Manger Cats, A V Bruschke
1Department of Cardiology, University Hospital, Leiden, The Netherlands.
Insights
Silent ischemia after myocardial infarction (MI) indicates poor prognosis. Diltiazem reduced asymptomatic ischemic ST-T changes and improved left ventricular function in post-MI patients, suggesting therapeutic potential.
Area of Science:
- Cardiology
- Clinical Medicine
- Exercise Physiology
Background:
- Silent ischemia following myocardial infarction (MI) has significant prognostic implications.
- Therapeutic intervention is considered due to the adverse effects of recurrent ischemia on left ventricular integrity.
Purpose of the Study:
- To assess the impact of diltiazem on asymptomatic ischemic ST-T changes and regional wall motion in patients post-MI.
- To explore the potential benefits of managing silent ischemia in early post-MI phase.
Main Methods:
- Evaluated 20 patients with asymptomatic ischemic ST-T changes on exercise testing early after MI.
- Measured exercise-induced ST-T depression and regional wall motion using radionuclide angiography before and after diltiazem administration.
Main Results:
- Diltiazem significantly reduced exercise-induced ST-T depression (2.3 to 0.7 mm, p<0.01).
- Regional wall-motion score at exercise showed significant improvement post-diltiazem (p<0.02).
Conclusions:
- Diltiazem effectively reduced silent ischemia parameters in early post-MI patients.
- Further research is warranted to quantify ischemic episodes and correlate with prognosis.
Abstract:
Silent ischemia after myocardial infarction has definite prognostic significance but should be interpreted within the context of other prognostic indicators. The rationale for therapeutic intervention is based on the prognostic implications of silent ischemia and the potentially deleterious effect of repeated episodes of ischemia on the integrity of the left ventricle. We measured parameters of ischemia in 20 patients who showed asymptomatic ischemic ST-T changes on exercise testing in the early phase after myocardial infarction. After diltiazem administration, a reduction of exercise-induced ST-T depression from 2.3 +/- 0.8 to 0.7 +/- 0.6 mm (p less than 0.01) occurred, and regional wall-motion score at exercise, determined by radionuclide angiography, improved significantly (p less than 0.02). These and other observations warrant further studies in which the duration, severity and frequency of the ischemic episodes should be quantified and correlated with prognosis after myocardial infarction.